AU2001272750A1 - Tumor-specific promoters - Google Patents
Tumor-specific promotersInfo
- Publication number
- AU2001272750A1 AU2001272750A1 AU2001272750A AU7275001A AU2001272750A1 AU 2001272750 A1 AU2001272750 A1 AU 2001272750A1 AU 2001272750 A AU2001272750 A AU 2001272750A AU 7275001 A AU7275001 A AU 7275001A AU 2001272750 A1 AU2001272750 A1 AU 2001272750A1
- Authority
- AU
- Australia
- Prior art keywords
- tumor
- specific promoters
- promoters
- specific
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
- A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000-220504 | 2000-07-21 | ||
JP2000220504 | 2000-07-21 | ||
PCT/JP2001/006228 WO2002010368A1 (en) | 2000-07-21 | 2001-07-18 | Tumor-specific promoters |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001272750A1 true AU2001272750A1 (en) | 2002-02-13 |
Family
ID=18715104
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001272750A Abandoned AU2001272750A1 (en) | 2000-07-21 | 2001-07-18 | Tumor-specific promoters |
Country Status (6)
Country | Link |
---|---|
US (2) | US7030099B2 (en) |
EP (2) | EP1302539A4 (en) |
JP (1) | JP4845327B2 (en) |
CN (1) | CN1252260C (en) |
AU (1) | AU2001272750A1 (en) |
WO (1) | WO2002010368A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003033514A1 (en) | 2001-10-19 | 2003-04-24 | Vascular Biogenics Ltd. | Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
AU2003222427B8 (en) | 2000-11-17 | 2010-04-29 | Vascular Biogenics Ltd. | Promoters exhibiting endothelial cell specificity and methods of using same |
US8071740B2 (en) * | 2000-11-17 | 2011-12-06 | Vascular Biogenics Ltd. | Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
US6856125B2 (en) * | 2001-12-12 | 2005-02-15 | Lifescan, Inc. | Biosensor apparatus and method with sample type and volume detection |
US7951532B2 (en) | 2003-11-12 | 2011-05-31 | Children's Hospital Medical Center | Method of screening a midkine modulating agent |
US7063947B2 (en) * | 2004-04-08 | 2006-06-20 | Promogen, Inc. | System for producing synthetic promoters |
AU2008307643B9 (en) | 2007-09-28 | 2014-04-17 | Intrexon Corporation | Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof |
CN101649319B (en) * | 2009-09-09 | 2011-11-30 | 陕西师范大学 | Tumor distinctive embedment promoter, constructing method and application thereof |
KR101497035B1 (en) * | 2010-04-26 | 2015-02-27 | 주식회사 녹십자 | Tumor-specific promoter and oncolytic virus vector comprising the same |
EP3591055A1 (en) | 2011-01-07 | 2020-01-08 | Applied Genetic Technologies Corporation | Promoters derived from the 5' nontranslated region (5'-ntr) of the human cyclic nucleotide gated beta 3 (cngb3) gene, expression cassettes and vectors comprising said promoters, for use treating achromatopsia and other diseases |
RU2476596C1 (en) * | 2012-02-02 | 2013-02-27 | Общество С Ограниченной Ответственностью "Ива" | Multi-purpose promoter, expression vector, and method of selective killing cancer cells with their use |
US9868960B2 (en) | 2013-05-10 | 2018-01-16 | National Brain Research Centre | Placental like alkaline phosphatase (PLAP) promoter mediated cell targeting |
KR20200116086A (en) * | 2018-01-26 | 2020-10-08 | 유니버시티 오브 피츠버그 - 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 | Expression of metabolic regulators in the tumor microenvironment to improve tumor treatment |
WO2022206962A1 (en) * | 2021-04-02 | 2022-10-06 | 深圳艾欣达伟医药科技有限公司 | Recombinant oncolytic virus and medical use thereof |
EP4329786A1 (en) | 2021-04-30 | 2024-03-06 | KaliVir Immunotherapeutics, Inc. | Oncolytic viruses for modified mhc expression |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994004196A1 (en) * | 1992-08-14 | 1994-03-03 | Imperial Cancer Research Technology Limited | Tumour therapy |
TW442569B (en) * | 1993-10-25 | 2001-06-23 | Canji Inc | Recombinant adenoviral vector |
US5518885A (en) * | 1994-04-19 | 1996-05-21 | The United States Of America As Represented By The Department Of Health & Human Services | ERBB2 promoter binding protein in neoplastic disease |
US5728379A (en) * | 1994-06-23 | 1998-03-17 | Georgetown University | Tumor- or cell-specific herpes simplex virus replication |
US5998205A (en) * | 1994-11-28 | 1999-12-07 | Genetic Therapy, Inc. | Vectors for tissue-specific replication |
US6432700B1 (en) * | 1997-03-03 | 2002-08-13 | Cell Genesys, Inc. | Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
US6607879B1 (en) * | 1998-02-09 | 2003-08-19 | Incyte Corporation | Compositions for the detection of blood cell and immunological response gene expression |
JP2002524525A (en) * | 1998-09-11 | 2002-08-06 | カリフォルニア・インスティテュート・オブ・テクノロジー | Regulation of oncogene HER / 2neu expression by synthetic polyamide |
CA2343078A1 (en) * | 1998-09-18 | 2000-03-30 | Kyowa Hakko Kogyo Co., Ltd. | Method for the diagnosis of cell proliferative disease |
-
2001
- 2001-07-18 EP EP01951914A patent/EP1302539A4/en not_active Withdrawn
- 2001-07-18 AU AU2001272750A patent/AU2001272750A1/en not_active Abandoned
- 2001-07-18 CN CNB018131573A patent/CN1252260C/en not_active Expired - Lifetime
- 2001-07-18 WO PCT/JP2001/006228 patent/WO2002010368A1/en active Application Filing
- 2001-07-18 US US10/333,013 patent/US7030099B2/en not_active Expired - Fee Related
- 2001-07-18 EP EP06026406A patent/EP1762614A3/en not_active Withdrawn
- 2001-07-18 JP JP2002516287A patent/JP4845327B2/en not_active Expired - Fee Related
-
2006
- 2006-01-12 US US11/331,307 patent/US20060099188A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP4845327B2 (en) | 2011-12-28 |
US7030099B2 (en) | 2006-04-18 |
US20060099188A1 (en) | 2006-05-11 |
US20030157065A1 (en) | 2003-08-21 |
EP1762614A2 (en) | 2007-03-14 |
CN1252260C (en) | 2006-04-19 |
EP1302539A1 (en) | 2003-04-16 |
EP1762614A3 (en) | 2007-05-30 |
EP1302539A4 (en) | 2004-10-27 |
CN1443238A (en) | 2003-09-17 |
WO2002010368A1 (en) | 2002-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001291151A1 (en) | N-acylsulfonamide apoptosis promoters | |
AU2001262847A1 (en) | Language-understanding | |
AU2001292739A1 (en) | 1-oxorapamycins | |
AU2001254546A1 (en) | Aminopiperidines | |
AU2000267458A1 (en) | Hypercomputer | |
AU2001239310A1 (en) | Decahydro-isoquinolines | |
AU2001220246A1 (en) | Neckphone | |
AU2001258349A1 (en) | Bisacylguanidine | |
AU2001279754A1 (en) | Indoloquinazolinones | |
AU2001272750A1 (en) | Tumor-specific promoters | |
AU2001281965A1 (en) | Novel 6-phenylphenanthridines | |
AU2001285886A1 (en) | 2-guanidino-4-aryl-quinazoline | |
AU2001290931A1 (en) | Ski-snowboard | |
AU2001293852A1 (en) | Sulfonylguanidine | |
AU2001258924A1 (en) | Microsatellite-aflp | |
AU2001281921A1 (en) | Bdellosomes | |
AU2001246864A1 (en) | Hypotensors | |
AU2001291876A1 (en) | Triazolo-epothilones | |
AU2001277581A1 (en) | Myocardium-specific promoter | |
AU2001260643A1 (en) | Ectocornea extension promoters | |
AU2002216268A1 (en) | Elongase promoters | |
AU2001268716A1 (en) | Novel chimeric promoters | |
AU2001226668A1 (en) | Crankshaft-starter-generator | |
AU2001260192A1 (en) | Glycinamides | |
AU2001284173A1 (en) | Calycins |